In 2022, there were 565 reported deaths due to tuberculosis, a significant decrease from 5,217 deaths in 1970. This statistic depicts the number of deaths due to tuberculosis in the United States from 1960 to 2022. Tuberculosis Disease Of all infectious diseases, tuberculosis (TB) remains one of the most deadly worldwide. TB is a contagious lung disease caused by bacteria and passed through the air from an infected person to others. It often remains dormant for a few years before presenting as an active case in about five percent of latent cases. Common symptoms include coughing, including coughing up blood, and unexplained weight loss as the infection begins to spread throughout the body. Without antibiotic treatment, about one third of those with an active infection will die within two years and another third within five years. At-risk Populations Although the death rate for TB in the United States and other developed countries has remained relatively low over the past thirty years, other countries are more heavily burdened by this disease. The regions of Africa and South-East Asia have the highest number of tuberculosis deaths worldwide. In 2022, there were around 632 thousand deaths due to tuberculosis in South-East Asia, compared to just 35 thousand in the Americas.

In 2023, there were around 15.5 deaths due to tuberculosis per 100,000 population worldwide. In comparison, the tuberculosis mortality rate in the year 2010 was 28.4 per 100,000 population. This statistic shows the mortality rate of tuberculosis worldwide from 2010 to 2023.

In 2023, there were around 1.25 million deaths due to tuberculosis worldwide. This statistic shows the number of tuberculosis deaths worldwide from 2010 to 2023.

Years of life lost due to mortality from tuberculosis (ICD-10 A15-A19). Years of life lost (YLL) is a measure of premature mortality. Its primary purpose is to compare the relative importance of different causes of premature death within a particular population and it can therefore be used by health planners to define priorities for the prevention of such deaths. It can also be used to compare the premature mortality experience of different populations for a particular cause of death. The concept of years of life lost is to estimate the length of time a person would have lived had they not died prematurely. By inherently including the age at which the death occurs, rather than just the fact of its occurrence, the calculation is an attempt to better quantify the burden, or impact, on society from the specified cause of mortality. Legacy unique identifier: P00461

In Canada, the death rate for tuberculosis (TB) has remained stable for the past twenty years. In 2023, around 0.3 out of 100 thousand Canadians died from TB. This statistic displays the age-standardized death rates for tuberculosis in Canada from 2000 to 2023. Tuberculosis Tuberculosis (TB) is a lung disease caused by a contagious bacterium spread through the air and was the deadliest communicable disease worldwide in 2019. The disease often remains dormant for a few years after infection, after which about five percent of those infected will develop active TB disease. Although reported cases have remained low in developed countries, many developing countries still struggle with higher rates. Moreover, individuals with HIV are at higher risk of developing and dying from an active TB infection, especially in high-burden countries. Prevention, treatment, and control Nowadays, antibiotics are the primary treatment modality for those infected with the bacterium causing TB. Efforts to reduce the burden of tuberculosis include enhancing prevention and control of cases of the disease, identification of risk factors, and treatment strategies for populations at risk of developing the active disease. Although reported cases have remained relatively low in Canada for the past thirty years, populations within the country at high risk include Indigenous peoples and foreign-born individuals.

Mortality from tuberculosis (ICD-10 A15-A19 equivalent to ICD-9 010-018). To reduce deaths from tuberculosis. Legacy unique identifier: P00486

In 2022, the rate of death from tuberculosis in the U.S. was .2 per every 100,000 population, a significant decrease from a rate of six in 1960. This statistic depicts the death rate for tuberculosis in the United States from 1960 to 2022.

Forecast: Number of Deaths Due to Tuberculosis (Excluding HIV Cases) in the US 2023 - 2027 Discover more data with ReportLinker!

Global Tuberculosis Death Rate by Country, 2023 Discover more data with ReportLinker!

Tuberculosis death rate (per 100,000 people) in Kiribati was reported at 37 % in 2023, according to the World Bank collection of development indicators, compiled from officially recognized sources. Kiribati - Tuberculosis death rate (per 100,000 people) - actual values, historical data, forecasts and projections were sourced from the World Bank on March of 2025.

Project Tycho datasets contain case counts for reported disease conditions for countries around the world. The Project Tycho data curation team extracts these case counts from various reputable sources, typically from national or international health authorities, such as the US Centers for Disease Control or the World Health Organization. These original data sources include both open- and restricted-access sources. For restricted-access sources, the Project Tycho team has obtained permission for redistribution from data contributors. All datasets contain case count data that are identical to counts published in the original source and no counts have been modified in any way by the Project Tycho team. The Project Tycho team has pre-processed datasets by adding new variables, such as standard disease and location identifiers, that improve data interpretabilty. We also formatted the data into a standard data format.

Each Project Tycho dataset contains case counts for a specific condition (e.g. measles) and for a specific country (e.g. The United States). Case counts are reported per time interval. In addition to case counts, datsets include information about these counts (attributes), such as the location, age group, subpopulation, diagnostic certainty, place of aquisition, and the source from which we extracted case counts. One dataset can include many series of case count time intervals, such as "US measles cases as reported by CDC", or "US measles cases reported by WHO", or "US measles cases that originated abroad", etc.

Depending on the intended use of a dataset, we recommend a few data processing steps before analysis:

• Analyze missing data: Project Tycho datasets do not inlcude time intervals for which no case count was reported (for many datasets, time series of case counts are incomplete, due to incompleteness of source documents) and users will need to add time intervals for which no count value is available. Project Tycho datasets do include time intervals for which a case count value of zero was reported.
• Separate cumulative from non-cumulative time interval series. Case count time series in Project Tycho datasets can be "cumulative" or "fixed-intervals". Cumulative case count time series consist of overlapping case count intervals starting on the same date, but ending on different dates. For example, each interval in a cumulative count time series can start on January 1st, but end on January 7th, 14th, 21st, etc. It is common practice among public health agencies to report cases for cumulative time intervals. Case count series with fixed time intervals consist of mutually exxclusive time intervals that all start and end on different dates and all have identical length (day, week, month, year). Given the different nature of these two types of case count data, we indicated this with an attribute for each count value, named "PartOfCumulativeCountSeries".

Tuberculosis death rate (per 100,000 people) in Ireland was reported at 0.37 % in 2023, according to the World Bank collection of development indicators, compiled from officially recognized sources. Ireland - Tuberculosis death rate (per 100,000 people) - actual values, historical data, forecasts and projections were sourced from the World Bank on March of 2025.

"BACKGROUND: Nearly 20% of tuberculosis (TB) patients die within one year, and TB-related mortality rates remain high in Taiwan. The study aimed to identify factors correlated with TB-specific deaths versus non-TB-specific deaths in different age groups among TB-related mortalities. METHODS: A retrospective cohort study was conducted from 2006-2008 with newly registered TB patients receiving follow-up for 1 year. The national TB database from the Taiwan-CDC was linked with the National Vital Registry System and the National Health Insurance database. A chi-squared test and logistic regression were used to analyse the correlated factors related to TB-specific and non-TB-specific deaths in different age groups. RESULTS: Elderly age (odds ratio [OR] 2.68-8.09), Eastern residence (OR 2.01), positive sputum bacteriology (OR 2.54), abnormal chest X-ray (OR 2.28), and comorbidity with chronic kidney disease (OR 2.35), stroke (OR 1.74) or chronic liver disease (OR 1.29) were most likely to be the cause of TB-specific deaths, whereas cancer (OR 0.79) was less likely to be implicated. For non-TB-specific deaths in patients younger than 65 years of age, male sex (OR 2.04) and comorbidity with HIV (OR 5.92), chronic kidney disease (OR 8.02), stroke (OR 3.75), cancer (OR 9.79), chronic liver disease (OR 2.71) or diabetes mellitus (OR 1.38) were risk factors. CONCLUSIONS: Different factors correlated with TB-specific deaths compared with non-TB-specific deaths, and the impact of comorbidities gradually decreased as age increased. To reduce TB-specific mortality, special consideration for TB patients with old age, Eastern residence, positive sputum bacteriology and comorbidity with chronic kidney disease or stroke is crucial. In particular, Eastern residence increased the risk of TB-specific death in all age groups. In terms of TB deaths among patients younger than 65 years of age, patients with HIV, chronic kidney disease or cancer had a 6-10 times increased risk of non-TB-specific deaths."

Tuberculosis is one of the deadliest communicable diseases worldwide, causing around 1.4 million deaths per year. Communicable diseases, also known as infectious diseases, are spread from person to person either directly or indirectly, such as through an insect bite or ingesting contaminated food or water. Some of the deadliest communicable diseases include HIV/AIDS, malaria, hepatitis C, cholera, and measles. Tuberculosis Tuberculosis is an infectious disease that affects the lungs. Tuberculosis disproportionately impacts the poorer, less developed countries of the world, such as in Africa and Southeast Asia. India reports the highest number of deaths from tuberculosis worldwide. HIV/AIDS Although deaths from HIV/AIDS have decreased over the last few decades, there were still around 630,000 AIDS-related deaths in 2023. Like many other communicable diseases, HIV/AIDS impacts developing regions more than the developed world. By far, the highest number of AIDS deaths come from Africa and Asia Pacific. Advancements in HIV treatment now allow those infected to live long and relatively normal lives, but access to treatment varies greatly.

Tuberculosis death rate (per 100,000 people) in Tunisia was reported at 1.2 % in 2023, according to the World Bank collection of development indicators, compiled from officially recognized sources. Tunisia - Tuberculosis death rate (per 100,000 people) - actual values, historical data, forecasts and projections were sourced from the World Bank on March of 2025.

Tuberculosis death rate of Nigeria plummeted by 15.87% from 63.0 cases per 100,000 people in 2020 to 53.0 cases per 100,000 people in 2021. Since the 1.59% climb in 2018, tuberculosis death rate sank by 17.19% in 2021. Tuberculosis death rate is the number of deaths from tuberculosis per 100,000 population. Incidence, prevalence and mortality estimates include patients with HIV. Estimates for all years are re-calculated as new information becomes available.

Tuberculosis death rate (per 100,000 people) in Ecuador was reported at 3 % in 2023, according to the World Bank collection of development indicators, compiled from officially recognized sources. Ecuador - Tuberculosis death rate (per 100,000 people) - actual values, historical data, forecasts and projections were sourced from the World Bank on March of 2025.

Forecast: Tuberculosis Death Rate in the UK 2024 - 2028 Discover more data with ReportLinker!

Poland Deaths: Male: IP: ow Tuberculosis data was reported at 384.000 Person in 2023. This records a decrease from the previous number of 389.000 Person for 2022. Poland Deaths: Male: IP: ow Tuberculosis data is updated yearly, averaging 418.000 Person from Dec 2005 (Median) to 2023, with 19 observations. The data reached an all-time high of 631.000 Person in 2005 and a record low of 349.000 Person in 2021. Poland Deaths: Male: IP: ow Tuberculosis data remains active status in CEIC and is reported by Statistics Poland. The data is categorized under Global Database’s Poland – Table PL.G006: Deaths: By Cause.

IntroductionThe primary aim of this study is to investigate and predict the prevalence and determinants of tuberculosis disease burden in China. Leveraging high-quality data sources and employing a methodologically rigorous approach, the study endeavors to enhance our understanding of tuberculosis control efforts across different regions of China. First, through nationwide spatio-temporal cluster analysis, we summarized the status of tuberculosis burden in various regions of China and explore the differences, thereby providing a basis for formulating more targeted tuberculosis prevention and control policies in different regions; Subsequently, using a time series-based forecasting model, we conducted the first-ever national tuberculosis burden trend forecast to offer scientific guidance for timely adjustments in planning and resource allocation. This research seeks to contribute significantly to China’s existing tuberculosis prevention and control system.Materials and methodsThis research draws upon publicly available pulmonary tuberculosis (PTB) incidence and mortality statistics from 31 provinces and municipalities of mainland China between 2004 and 2018. We organized and classified these data according to province, month, year, and patient age group. Overall, the sample included 14,816,329 new instances of PTB and 42,465 PTB-related fatalities. We used spatiotemporal cluster analysis to record the epidemiological characteristics and incidence patterns of PTB during this period. Additionally, a time series model was constructed to forecast and analyze the incidence and mortality trends of PTB in China.ResultsThis study reveals significant regional variations in PTB incidence and mortality in China. Tibet (124.24%) and Xinjiang (114.72%) in western China exhibited the largest percentage change in tuberculosis (TB) incidence, while Zhejiang Province (−50.45%) and Jiangsu Province (−51.33%) in eastern China showed the largest decreases. Regions with significant percentage increases in PTB mortality rates (>100%) included four western regions, six central regions, and five eastern regions. The regions with relatively large percentage decreases in the mortality rate of PTB include Tianjin (−52.25%) and Shanghai (−68.30%). These differences are attributed to two main factors: (1) economic imbalances leading to poor TB control in underdeveloped areas, and (2) differences in TB-related policies among provinces causing uneven distribution of disease risks. Consequently, China may still face challenges in achieving the World Health Organization’s 2030 tuberculosis control goals. Nationwide, the mortality rate of PTB in China increased between 2004 and 2018 (percentage change: 105.35%, AAPC: 4.1), while the incidence of PTB showed a downward trend (percentage change: -20.59%, AAPC: −2.1). Among different age groups, the 0–19 age group has the smallest disease burden. While incidence and mortality from TB were primarily found in adults 60 years of age or older, the age group of 0–19 years has the smallest burden of TB, highlighting obvious differences in age characteristics. It is predicted that the mortality rate of TB in China will continue to increase. In summary, the TB epidemic in China has been largely controlled due to the implementation of many public health programs and policies targeting specific groups and geographical areas. Finding and supporting effective health programs will make it possible to achieve the World Health Organization’s goal of controlling tuberculosis in China.